Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

NOVI REFERENCE LABORATORY

NPI: 1760864094 · NOVI, MI 48375 · Clinical Medical Laboratory · NPI assigned 06/23/2015

$178K
Total Medicaid Paid
3,447
Total Claims
3,380
Beneficiaries
8
Codes Billed
2018-01
First Month
2019-06
Last Month

Provider Details

Authorized OfficialSUBRAMANIAM, SUCHITRA (ADMINISTRATOR)
NPI Enumeration Date06/23/2015

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,076 $107K
2019 1,371 $71K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 947 931 $116K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,189 1,166 $44K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 143 142 $16K
84311 104 102 $2K
83986 110 108 $444.23
83789 644 628 $366.66
82570 74 73 $188.36
82542 236 230 $96.25